Covid-19 Impact on Autoimmune Disease Diagnosis Market: Updated Study Offering Insights & Analysis up to 2026

October 22nd,2021/IndustryNewsGlobal/ -- This new report from Stratview Research analyses the Autoimmune Disease Diagnosis Market over the trend period from 2015 to 2020 and forecast period from 2021 to 2026. The insights of the report shall enable informed decision making and strategy formulation for the near future to capitalize on the opportunities.

 

Autoimmune Disease Diagnosis Market Overview:

The sudden outbreak of the COVID-19 has led to unforeseen fluctuations across many industries and the Autoimmune Disease Diagnosis Market is no different. Derived from the previous market scenario, the Autoimmune Disease Diagnosis Market is likely to witness a CAGR of 8.2% during the forecast period but with the global crisis in action, the growth curve has deviated from its expected path and exhibits an uncertain trajectory at present. 


Key Players:

  • Abbott Laboratories

  • Bio-Rad Laboratories Inc.

  • Danaher Corporation

  • Euroimmun AG

  • Grifols S.A.

  • Hycor Biomedical Inc.

  • Siemens AG

  • Thermo Fisher Scientific

  • Trinity Biotech plc

  • Werfen

  • Others


The Autoimmune Disease Diagnosis Market is segmented by–

·         by Product Type (Consumables & Assay Kits, Instruments),

·         by Test Type (Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Tests, and Other Tests),

·         by Disease Type (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjogren’s Syndrome, Thyroiditis, Scleroderma, and Other Diseases),

·         by End-User Type (Clinical Laboratories, Hospitals, and Others),

·         by Region (North America, Europe, Asia-Pacific, and Rest of the World).


Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/886/autoimmune-disease-diagnosis-market.html#form


Regional analysis:

In terms of regions, Europe is estimated to remain the largest market during the forecast period due to the rising chronic diseases such as rheumatoid arthritis among the increasing ageing population. Autoimmune diseases affect 5-10% of the population in Europe and North America. The 3TR project (taxonomy, treatments, targets and remission) funded by the EU’s Innovative Medicines Initiative with €80 million for the next seven years to discover biomarkers that can predict which patients will respond best to the treatments for autoimmune diseases is another significant factor contributing to the growth of the region’s market.


About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.


For enquiries,
Contact:
Stratview Research
E-mail: 
sales@stratviewresearch.com
Direct: +1-313-307-4176


Join